跳至主要内容
临床试验/NL-OMON43808
NL-OMON43808已完成2 期

TElmisartan in the management of abDominal aortic aneurYsm (TEDY) - TEDY

eids Universitair Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • AAA measuring a maximum diameter of 35-49 mm on CTA or ultrasound
  • No current indication for AAA repair according to the treating physician or expectation that this will be revised within the next year
  • High likelihood of compliance with treatment over 24 months

排除标准

  • Contraindications to study treatment, including: renal impairment (i.e. creatinine >1.5x upper limit of normal [ULN]), known significant renal stenosis (>70%) of one or both renal arteries, chronic liver disease (i.e. cirrhosis or hepatitis) or abnormal liver function (i.e. ALT 1.5xULN), electrolyte imbalance and gout. No previous abdominal aortic surgery.
  • Current or planned usage of an AT1 blocker or ACE inhibitors

研究者

相似试验